These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

781 related items for PubMed ID: 28230459

  • 21. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
    Korcegez EI, Sancar M, Demirkan K.
    J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
    [Abstract] [Full Text] [Related]

  • 22. Effect of a Virtual Pharmacy Review Program: A Population Health Case Study.
    Muraywid B, Butkievich LE, Myers B.
    J Manag Care Spec Pharm; 2020 Jan; 26(1):24-29. PubMed ID: 31880223
    [Abstract] [Full Text] [Related]

  • 23. Clinical and Economic Effects of a Pharmacist-Administered Antiretroviral Therapy Adherence Clinic for Patients Living with HIV.
    Dilworth TJ, Klein PW, Mercier RC, Borrego ME, Jakeman B, Pinkerton SD.
    J Manag Care Spec Pharm; 2018 Feb; 24(2):165-172. PubMed ID: 29384024
    [Abstract] [Full Text] [Related]

  • 24. Effect of Diabetes Treatment-Related Attributes on Costs to Type 2 Diabetes Patients in a Real-World Population.
    Meng J, Casciano R, Lee YC, Stern L, Gultyaev D, Tong L, Kitio-Dschassi B.
    J Manag Care Spec Pharm; 2017 Apr; 23(4):446-452. PubMed ID: 28345434
    [Abstract] [Full Text] [Related]

  • 25. Maintenance of Clinical Endpoints After Discharge from a Pharmacist-Managed Risk Reduction Clinic at a Veterans Affairs Medical Center.
    Sherrill CH, Pentecost A, Wood EE.
    J Manag Care Spec Pharm; 2016 Jan; 22(1):14-20. PubMed ID: 27015047
    [Abstract] [Full Text] [Related]

  • 26. Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetes.
    Guzauskas GF, Rind DM, Fazioli K, Chapman RH, Pearson SD, Hansen RN.
    J Manag Care Spec Pharm; 2021 Apr; 27(4):455-468. PubMed ID: 33769850
    [Abstract] [Full Text] [Related]

  • 27. Impact of Out-of-Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes.
    Bibeau WS, Fu H, Taylor AD, Kwan AY.
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1338-1347. PubMed ID: 27783549
    [Abstract] [Full Text] [Related]

  • 28. Michigan Pharmacists Transforming Care and Quality: Developing a Statewide Collaborative of Physician Organizations and Pharmacists to Improve Quality of Care and Reduce Costs.
    Choe HM, Lin AT, Kobernik K, Cohen M, Wesolowicz L, Qureshi N, Leyden T, Share DA, Darland R, Spahlinger DA.
    J Manag Care Spec Pharm; 2018 Apr; 24(4):373-378. PubMed ID: 29578853
    [Abstract] [Full Text] [Related]

  • 29. Clinical pharmacist intervention and the proportion of diabetes patients attaining prevention objectives in a multispecialty medical group.
    Padiyara RS, D'Souza JJ, Rihani RS.
    J Manag Care Pharm; 2011 Apr; 17(6):456-62. PubMed ID: 21787031
    [Abstract] [Full Text] [Related]

  • 30. Cost-effectiveness of insulin glargine versus NPH insulin for the treatment of Type 2 diabetes mellitus, modeling the interaction between hypoglycemia and glycemic control in Switzerland.
    Brändle M, Azoulay M, Greiner RA.
    Int J Clin Pharmacol Ther; 2011 Mar; 49(3):217-30. PubMed ID: 21329624
    [Abstract] [Full Text] [Related]

  • 31. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
    Altavela JL, Jones MK, Ritter M.
    J Manag Care Pharm; 2008 Mar; 14(9):831-43. PubMed ID: 19006440
    [Abstract] [Full Text] [Related]

  • 32. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T.
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [Abstract] [Full Text] [Related]

  • 33. Budget Impact Analysis of a Pharmacist-Provided Transition of Care Program.
    Ni W, Colayco D, Hashimoto J, Komoto K, Gowda C, Wearda B, McCombs J.
    J Manag Care Spec Pharm; 2018 Feb; 24(2):90-96. PubMed ID: 29384028
    [Abstract] [Full Text] [Related]

  • 34. The Effect of Clinical Pharmacist-Led Comprehensive Medication Management on Chronic Disease State Goal Attainment in a Patient-Centered Medical Home.
    Prudencio J, Cutler T, Roberts S, Marin S, Wilson M.
    J Manag Care Spec Pharm; 2018 May; 24(5):423-429. PubMed ID: 29694290
    [Abstract] [Full Text] [Related]

  • 35. Economic evaluations of pharmacist-managed services in people with diabetes mellitus: a systematic review.
    Wang Y, Yeo QQ, Ko Y.
    Diabet Med; 2016 Apr; 33(4):421-7. PubMed ID: 26433008
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of a Pharmacist-Managed Antidiabetic Deprescribing Program in an Integrated Health Care System.
    Hui RL, Chang CC, Niu F, Tang YK, Harano D, Deguzman L, Kao DJ, Awsare S, Draves M.
    J Manag Care Spec Pharm; 2019 Aug; 25(8):927-934. PubMed ID: 31347983
    [Abstract] [Full Text] [Related]

  • 37. Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large U.S. Managed Care Population.
    Grabner M, Peng X, Geremakis C, Bae J.
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1204-12. PubMed ID: 26679969
    [Abstract] [Full Text] [Related]

  • 38. Cost effectiveness of insulin glargine plus oral antidiabetes drugs compared with premixed insulin alone in patients with type 2 diabetes mellitus in Canada.
    Tunis SL, Sauriol L, Minshall ME.
    Appl Health Econ Health Policy; 2010 Dec; 8(4):267-80. PubMed ID: 20578781
    [Abstract] [Full Text] [Related]

  • 39. Medication therapy management: 10 years of experience in a large integrated health care system.
    Ramalho de Oliveira D, Brummel AR, Miller DB.
    J Manag Care Pharm; 2010 Apr; 16(3):185-95. PubMed ID: 20331323
    [Abstract] [Full Text] [Related]

  • 40. Long-term Cost-effectiveness of Two GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus in the Italian Setting: Liraglutide Versus Lixisenatide.
    Hunt B, Kragh N, McConnachie CC, Valentine WJ, Rossi MC, Montagnoli R.
    Clin Ther; 2017 Jul; 39(7):1347-1359. PubMed ID: 28625506
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.